Showing results (381-390 of 416) with videos related to
Sort By:
Pageof 42
Cancers|August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapyShivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.The Lancet. HIV|July 15, 2021
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting studyRobin Schaefer, Heather-Marie A Schmidt, Giovanni Ravasi, et al.Neuro-Oncology Practice|May 13, 2024
App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE)Lorenz Dörner, Lucia Grosse, Felix Stange, et al.Journal of the International AIDS Society|March 15, 2018
A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholdersPeter D Ehrenkranz, Jesus Mg Calleja, Wafaa El-Sadr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV InfectionJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.The Pharmacogenomics Journal|June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyMaja Guberina, Ali Sak, Christoph Pöttgen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2018
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapyStefan Schmidt, Annett Linge, Alex Zwanenburg, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2026
A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C)Bouchra Tawk, Gordana Halec, Katrin Rein, et al.Pageof 42